Robyn Emmins

842 total citations
8 papers, 628 citations indexed

About

Robyn Emmins is a scholar working on Molecular Biology, Genetics and Ecology. According to data from OpenAlex, Robyn Emmins has authored 8 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Ecology. Recurrent topics in Robyn Emmins's work include Bacterial Genetics and Biotechnology (5 papers), Bacteriophages and microbial interactions (3 papers) and RNA and protein synthesis mechanisms (3 papers). Robyn Emmins is often cited by papers focused on Bacterial Genetics and Biotechnology (5 papers), Bacteriophages and microbial interactions (3 papers) and RNA and protein synthesis mechanisms (3 papers). Robyn Emmins collaborates with scholars based in United Kingdom, United States and Japan. Robyn Emmins's co-authors include Richard A. Daniel, Jeff Errington, Dennis Claessen, Leendert W. Hamoen, D. H. Edwards, Louise Weston, Catriona Donovan, Marc Bramkamp, Yoshikazu Kawai and Shu Ishikawa and has published in prestigious journals such as The EMBO Journal, Molecular Microbiology and Clinical & Experimental Immunology.

In The Last Decade

Robyn Emmins

8 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robyn Emmins United Kingdom	6	401	377	199	109	68	8	628
Paola Bisicchia Ireland	11	546 1.4×	496 1.3×	281 1.4×	138 1.3×	62 0.9×	11	829
Manuel Pazos United Kingdom	15	387 1.0×	375 1.0×	199 1.0×	120 1.1×	49 0.7×	20	722
Katrin Beilharz Netherlands	9	438 1.1×	365 1.0×	179 0.9×	67 0.6×	159 2.3×	11	738
Mirjana Lilić United States	16	356 0.9×	269 0.7×	128 0.6×	145 1.3×	126 1.9×	24	755
Robert Sijbrandi Netherlands	9	389 1.0×	375 1.0×	231 1.2×	60 0.6×	33 0.5×	10	652
Anna‐Barbara Hachmann United States	8	660 1.6×	415 1.1×	259 1.3×	114 1.0×	25 0.4×	10	897
Edwige Madec France	14	330 0.8×	220 0.6×	111 0.6×	72 0.7×	64 0.9×	18	542
Nathan W. Rigel United States	16	401 1.0×	301 0.8×	91 0.5×	178 1.6×	123 1.8×	20	707
Timothy R. Mack United States	9	464 1.2×	315 0.8×	92 0.5×	121 1.1×	85 1.3×	9	663
João M. Monteiro Portugal	9	348 0.9×	243 0.6×	151 0.8×	210 1.9×	27 0.4×	12	603

Countries citing papers authored by Robyn Emmins

Since Specialization

Citations

This map shows the geographic impact of Robyn Emmins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn Emmins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn Emmins more than expected).

Fields of papers citing papers by Robyn Emmins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn Emmins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn Emmins. The network helps show where Robyn Emmins may publish in the future.

Co-authorship network of co-authors of Robyn Emmins

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn Emmins. A scholar is included among the top collaborators of Robyn Emmins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn Emmins. Robyn Emmins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Clarke, Howard R. G., Anke Mayer‐Bartschmid, Mark Moffat, et al.. (2024). When will we have a clone? An industry perspective on the typical CLD timeline. Biotechnology Progress. 40(4). e3449–e3449. 3 indexed citations

Wu, Paul Y K, Louise Almond, Jennitte Stevens, et al.. (2019). Advancing Biologics Development Programs with Legacy Cell Lines: Advantages and Limitations of Genetic Testing for Addressing Clonality Concerns Prior to Availability of Late Stage Process and Product Consistency Data. PDA Journal of Pharmaceutical Science and Technology. 74(2). 264–274. 2 indexed citations

Sassine, Jad, et al.. (2017). Functional redundancy of division specific penicillin‐binding proteins in Bacillus subtilis. Molecular Microbiology. 106(2). 304–318. 26 indexed citations

Morley, Peter J., Tracey J. Wright, Mary Birchler, et al.. (2015). Specificity of human anti-variable heavy (VH) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis factor-α receptor 1. Clinical & Experimental Immunology. 182(2). 139–148. 33 indexed citations

Kawai, Yoshikazu, Jon Marles‐Wright, Robert M. Cleverley, et al.. (2011). A widespread family of bacterial cell wall assembly proteins. The EMBO Journal. 30(24). 4931–4941. 201 indexed citations

Fukushima, Tatsuya, et al.. (2010). A role for the essential YycG sensor histidine kinase in sensing cell division. Molecular Microbiology. 79(2). 503–522. 55 indexed citations

Bramkamp, Marc, Robyn Emmins, Louise Weston, et al.. (2008). A novel component of the division‐site selection system of Bacillus subtilis and a new mode of action for the division inhibitor MinCD. Molecular Microbiology. 70(6). 1556–1569. 135 indexed citations

Claessen, Dennis, Robyn Emmins, Leendert W. Hamoen, et al.. (2008). Control of the cell elongation–division cycle by shuttling of PBP1 protein in Bacillus subtilis. Molecular Microbiology. 68(4). 1029–1046. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact